SCHEMBL3480978

SCHEMBL3480978

OCc1cc(OCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c(OCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c(OCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516266 1.00 ALOX15 (0.30) ALOX15TSHRHSD17B10
SCHEMBL13888674 0.83 S1PR1 (0.31)
SCHEMBL3480730 0.82 CNR1 (0.31)
SCHEMBL6532147 0.79 FDPS (0.37)
SCHEMBL3480760 0.79 TSHR (0.37) TSHR
SCHEMBL3480785 0.78 CA1 (0.37)
SCHEMBL3046890 0.77 PLA2G2D (0.37) TSHRHSD17B10
SCHEMBL3779536 0.77 HRH3 (0.42)
SCHEMBL3424352 0.77 HRH3 (0.42)
SCHEMBL27096233 0.75 HRH3 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907452-B1 NOVEL SURFACE ACTIVE POLYMERIC-DENDRON SYSTEMS UNIV DURHAM (GB) 2017-04-05 EP disclosed
US-9487631-B2 Surface active polymeric systems UNIVERSITY OF DURHAM (GB) 2016-11-08 US disclosed
US-9024053-B2 Compound obtained by dimerizing with light irradiation, a compound containing a group having lyophilicity, and a compound containing a group having liquid-repellency JOLED INC. (JP) 2015-05-05 US disclosed
US-9024053-B2 Compound obtained by dimerizing with light irradiation, a compound containing a group having lyophilicity, and a compound containing a group having liquid-repellency JOLED INC. (JP) 2015-05-05 US disclosed
US-8847211-B2 Device, thin film transistor, method for manufacturing the device and method for manufacturing the thin film transistor PANASONIC CORPORATION (JP) 2014-09-30 US disclosed
US-8847211-B2 Device, thin film transistor, method for manufacturing the device and method for manufacturing the thin film transistor PANASONIC CORPORATION (JP) 2014-09-30 US disclosed
US-20120330047-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-27 US disclosed
US-20120330047-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-27 US disclosed
US-20120319090-A1 DEVICE, THIN FILM TRANSISTOR, METHOD FOR MANUFACTURING THE DEVICE AND METHOD FOR MANUFACTURING THE THIN FILM TRANSISTOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-20 US disclosed
US-20120319090-A1 DEVICE, THIN FILM TRANSISTOR, METHOD FOR MANUFACTURING THE DEVICE AND METHOD FOR MANUFACTURING THE THIN FILM TRANSISTOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-20 US disclosed
US-20100036054-A1 NOVEL SURFACE ACTIVE POLYMERIC SYSTEMS UNIVERSITY OF DURHAM (GB) 2010-02-11 US disclosed
EP-1907452-A1 NOVEL SURFACE ACTIVE POLYMERIC SYSTEMS UNIVERSITY OF DURHAM (GB) 2008-04-09 EP disclosed
WO-2006125965-A1 NOVEL SURFACE ACTIVE POLYMERIC SYSTEMS UNIVERSITY OF DURHAM (GB) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120330047-A1 COMPOUND F10, CFD, INF2 ALOX15 2125/4885TSHR 4113/4885HSD17B10 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.